KDM1A and breast cancer: Compound 55, the best potent LSD1 inhibitor of them, is reversible and specific for LSD1 and inhibits the proliferation and survival of seven BC cell lines with IC50 from 0.468 to 2.730 μM range, which is more potent than a known MAO inhibitor 2-PCPA.